Savient Pharmaceuticals (SVNT) Misses All Q1 Expectations
Tweet Send to a FriendGet Alerts SVNT Hot Sheet
Price: $0.75 -6.25%
EPS Growth %: +30.6%
Financial Fact:
Income tax benefit: 2.24M
Today's EPS Names:
MPAA, LTON, KFY, More
EPS Growth %: +30.6%
Financial Fact:
Income tax benefit: 2.24M
Today's EPS Names:
MPAA, LTON, KFY, More
Trade SVNT Now!
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $4.59 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- Restoration Hardware Holdings (RH) Tops Q1 EPS by 2c, Guidance Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
